| Literature DB >> 22032784 |
M Miraglia Del Giudice1, G L Marseglia, S Leonardi, M A Tosca, A Marseglia, L Perrone, G Ciprandi.
Abstract
Exaled nitric oxide (FeNO) is considered a good noninvasive marker to assess airway inflammation in asthma and allergic rhinitis. In asthma, exhaled NO is very useful to verify adherence to therapy, and to predict upcoming asthma exacerbations. It has been also proposed that adjusting anti-inflammatory drugs guided by the monitoring of exhaled NO, could improve overall asthma control. Other studies showed increased FeNO levels in subjects with allergic rhinitis.Entities:
Mesh：
Substances：
Year: 2011 PMID： 22032784 DOI： 10.1177/03946320110240s407
Source DB: PubMed Journal: Int J Immunopathol Pharmacol ISSN： 0394-6320 Impact factor: 3.219